Novel treatment options for portal hypertension.

about

Editorial: getting bullish about portal hypertension-chronic treatment with oral taurine?Managing portal hypertension in patients with liver cirrhosis.The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

P2860

Q48228708-39CA4C91-80F7-4720-BDD7-F52410EFD124 Q55278061-0DACAC50-E747-4AD1-868F-87CC83F54876 Q55340936-8D6CA290-6D07-40AB-816D-A00C0E9CA3E2

P2860

Novel treatment options for portal hypertension.

Item

http://www.wikidata.org/entity/Q38680437

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel treatment options for portal hypertension.

@en

type

Item

label

Novel treatment options for portal hypertension.

@en

prefLabel

Novel treatment options for portal hypertension.

@en

P1476

Novel treatment options for portal hypertension.

@en

P2093

Philipp Schwabl

http://www.w3.org/2001/XMLSchema#string

P2860

Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice

New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials

Intestinal permeability in a patient with liver cirrhosis

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

FXR-mediated regulation of eNOS expression in vascular endothelial cells

Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers

Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response

P304

90-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GASTRO/GOX011

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wim J Laleman

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28533907

http://www.w3.org/2001/XMLSchema#string

P932

5421460

http://www.w3.org/2001/XMLSchema#string

Novel treatment options for portal hypertension.

about

P2860

P2860

Novel treatment options for portal hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932